Doramapimod HCl is the salt form of Doramapimod, a member of the N-pyrazole-N-naphthly urea class of p38MAPK inhibitors, which binds to the kinase with both slow association and dissociation rates. BIRB -796 has entered clinical trials for the treatment of autoimmune diseases.
Molecular Weight:
564.13
CAS Number:
[1283526-53-3]
Formula:
C31H38ClN5O3
Target:
Others|||Raf|||Autophagy|||p38 MAPK
T71058
* VAT and and shipping costs not included. Errors and price changes excepted